MYCN and neuroblastoma: Directly targeting MYCN mRNA or MYCN gene at the level of DNA using MYCN-specific oligonucleotides is another highly promising and valuable approach for the specific, effective and safe treatment of MYCN-related HR-NB and other MYCN-expressing tumors.